¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Dextrose/ Fructose/ Phosphoric Acid Solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • stearic acid
    ½ºÅ׾Ƹ£»ê
  • succinic acid
    ¼÷½Å»ê
  • sugar acid
    ´ç»ê
  • sulfuric acid
    Ȳ»ê
  • sulfurous acid
    ¾ÆÈ²»ê
  • salicylic acid
    »ì¸®½Ç»ê
  • sialic acid
    ½Ã¾Ë»ê
  • taurocholic acid
    Ÿ¿ì·ÎÄÝ»ê
  • teichoic acid
    Å×ÀÌÄÚ»ê
  • teichuronic acid
    Å×ÀÌÅ¥·Ð»ê
  • tannic acid
    ź´Ñ»ê
  • tartaric acid
    Ÿ¸£Å¸¸£»ê
  • unsaturated fatty acid
    ºÒÆ÷È­Áö¹æ»ê
  • uric acid
    ¿ä»ê
  • uric acid infarct
    ¿ä»ê°æ»ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • periodic acid-Schiff stain
    ÇÇ¿¡ÀÌ¿¡½º¿°»ö
  • uric acid stone
    ¿ä»êµ¹
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê(Ý×ûù â©áÈß«)
  • hydroparacumaric acid
    È÷µå·ÎÄí¸¶¸°»ê.
  • hydroxamic acid
    È÷µå·Ï»ï»ê(¡­ß«).
  • hydroxyindoleacetic acid = 5-HIAA
    5-ÇÏÀ̵å·Ï½ÃÀε¹ÃÊ»ê
  • indoxyl carbonic acid ester
    Àε¶½Çź»ê¿¡½ºÅ׸£
  • inosinic acid
    À̳ë½Å»ê.
  • phocenic acid
    ±æÃÊ»ê(ÑÎõ³ß«).
  • phosphopyruvic acid
    Æ÷½ºÆ÷ÇǺ긣»ê.
  • phosphotungstic acid hematoxylin =ptah
    ÀÎ(ìÝ)ÅÖ½ºÅÙ»êÇ츶Åå½Ç¸°
  • picramic acid
    ÇÇÅ©¶÷»ê(¡­ß«).
  • polyunsaturate fatty acid
    ´Ù(Òý)ºÒÆ÷È­Áö¹æ»ê.
  • propionic acid
    ÇÁ·ÎÇǿ»ê(¡­ß«).
  • prostatic acid phosphatase
    Àü¸³¼±»êÀλêÈ¿¼Ò(Æ÷½ºÆÄŸÁ¦)(îñí¡àÍß«×òß«ý£áÈ)
  • pteroylmonoglutamic acid
    Å×·ÎÀϸð³ë±Û·çŽ»ê(¡­ß«)
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê(¡­ß«).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • carbonic acid
    ź»ê.
  • carbonic acid
    ź»ê
  • carbonic acid
    ź»ê
  • carbonic acid
    ź»ê(÷©ß«)
  • carbonic acid assimilation
    ź¼Òµ¿È­ (¡­ÔÒûù).
  • cell wall teichoic acid
    ¼¼Æ÷º® ŸÀÌÄÚ»ê
  • cellular retinoid acid-bindin gprotein
    ¼¼Æ÷³» ·¹Æ¼³ëÀ̵å»ê°áÇմܹé(¡­Ì¿ùêÓ±ÛÜ)
  • cerebric acid
    ³ú»ê(Òàß«).
  • cerebronic acid
    ¼¼·¹ºê·Ð»ê.
  • chamber acid
    ¿¬½ÇȲ»ê(æçãøüÜß«).
  • chenodeoxycholic acid
    Äɳ뵥¿Á½ÃÄݸ°»ê
  • chitonic acid
    Űſ»ê(¡­ß«)
  • cholic acid
    ´ãÁó»ê
  • cholic acid
    ÄÝ»ê(ß«)
  • chondroitin sulfuric acid =chs
    Äܵå·ÎÀÌÆ¾È²»ê(¡­üÜß«).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
  • inosinic acid
    À̳ë½Å»ê(ß«)
  • isoascorbic acid
    ¾ÆÀ̼ҾƽºÄÚ¸£ºó»ê
  • isocitric acid
    ¾ÆÀ̼һçÀÌÆ®¸£»ê(ß«)
  • iso fatty acid
    ¾ÆÀ̼ÒÁö¹æ»ê(ò·Û¸ß«)
  • isonicotinic acid hydrazide
    ¾ÆÀ̼ҴÏÄÚÆ¾»ê(ß«) ÇÏÀ̵å¶óÁöµå
  • ketogenic amino acid
    ÄÉÅæ»ý¼º(ßæà÷) ¾Æ¹Ì³ë»ê(ß«)
  • -ketoglutaric acid
    -ÄÉÅ䱸¸£Å¸¸£»ê(ß«)
  • lactic acid
    ¶ôÆ®»ê(ß«)
  • lactic acid fermentation
    ¶ôÆ®»ê(ß«)¹ßÈ¿(Û£ý£)
  • lauric acid
    ¶ó¿ì¸£»ê(ß«)
  • Lewis acid
    ·çÀ̽º»ê(ß«)
  • Lewis acid-base catalysis
    ·çÀ̽º »ê-¿°±â(ß«.ç¤Ðñ) Ã˸ÅÀÛ¿ë(ç¤Ðñ õºØÚÚãëë)
  • lignoceric acid
    ¸®±×³ë¼¼¸£»ê(ß«)
  • limiting amino acid
    Á¦ÇÑ(ð¤ùÚ)¾Æ¹Ì³ë»ê(ß«)
  • linoleic acid
    ¸®³î·¹»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
PD Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p...
PSD particle size distribution; peptone, starch, and dextrose; periodic synchronous discharge; phase-sen...
WD wallerian degeneration; well developed; well differentiated; wet dressing; Whitney Damon [dextrose];...
Sol. Solution
s.s. soap solution; ºñ´°¹°
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 15
1-MU 1-methyl uric acid
NAA 1-naphthaleneacetic acid
PBA 1-pyrene butyric acid
DDATHF 10-dideazatetrahydrofolic acid
HETE 11-hydroxyeicosatetraenoic acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ulmic acid
    ¿ï¹Î»ê
    ´À¸¨³ª¹« Áó¿¡¼­ ¾ò¾îÁö´Â À¯±â»ê.
  • umbellic acid
    ¿òº§»ê
  • unesterified fatty acid
    ºñ¿¡½ºÅ׸£È­ Áö¹æ»ê
  • uric acid test
    ¿ä»ê °Ë»ç
  • urocanic acid
    ¿ì·ÎÄ«´Ñ»ê
    È÷½ºÅ¸¹ÎÀÇ Áß°£ ´ë»ç »ê¹°. º¸Åë ±Û·çŸ¹Î»êÀ¸·Î ÀüȯµÈ´Ù.
  • urodeoxycholic acid
    ¿ì¸£¼Ò µð¿Á½ÃÄÝ»ê
    »ç¶÷¿¡°Ô´Â ¼Ò·®¸¸ÀÌ Á¤»óÀûÀ¸·Î Á¸ÀçÇÏ´Â ´ãÁó»ê. chenodeoxycholic acidÀÇ À̼ºÃ¼. °õÀÇ ´ãÁó¿¡¼­ óÀ½À¸·Î ºÐ¸®µÇ¾ú´Ù. ÄÝ·¹½ºÅ×·Ñ ´ã¼®À» ¿ëÇØ½Ã۱â À§Çؼ­ Åõ¿©µÈ´Ù.
  • uroleucic acid
    ¿ì·Î·ù½Å»ê
    °áÁ¤»ê. ¾Ëİſ´¢Áõ ȯÀÚÀÇ ¿ä¿¡¼­ ¹ß°ßµÈ´Ù.
  • uronic acid
    ¿ì·Ð»ê
    ´Ü´ç·ù ź¼Ò¼âÀÇ ¾ËÄݱ⠸»´ÜÀÇ »êÈ­¿¡ ÀÇÇØ »ý¼ºµÈ ¾Ëµ¥ÇÏÀ̵å»ê.
  • valproic acid
    ¹ßÇÁ·Î»ê, º§ÇÁ·ÎÀÍ»ê
    2-ÇÁ·ÎÇÊÆæÅ¸³ëÀÍ »ê. 8°³ÀÇ Åº¼Ò Ãø¼â¸¦ °®´Â Áö¹æ»ê. Ç×°£ÁúÁ¦ÀÌ´Ù.
  • vanillyl mandelic acid
    ¹Ù´Ò¸± ¸¸µ¨»ê
    Ä«Å×ÄݾƹÎÀÇ ¸¶Áö¸· ´ë»ç¹°.
  • vinylacetic acid
    ºñ´Ò ÃÊ»ê
  • volatile acid
    Èֹ߼º »ê
  • weak acid
    ¾à»ê
    ÇØ¸®µµ°¡ ³·Àº »ê
  • xanthenuric acid
    Ű»êÅ×´©¸£ »ê
    Æ®¸³ÅäÆÇ¿¡¼­ Ű´­·¹´Ñ¼ö»êÈ­ Ű´­·¹´ÑÀ» °ÅÃÄ »ý±â´Â À¯±â»ê.
  • xanthourenic acid
    ÀÜÅõ·»»ê
    4,8-dihydroxyquinaldic acid. L-try
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 15
amino acid reagent A reagent used in the identification and quantification of amino acids.
(05 Mar 2000)
amino acid receptor <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor.
(18 Nov 1997)
amino acid sequence The sequence of amino acids as arrayed in chains, sheets, etc., within the protein molecule. This is referred to as the primary structure of proteins. It is of fundamental importance in determining protein conformation.
(12 Dec 1998)
amino acid substitution The naturally occurring or experimentally induced replacement of one or more amino acids in a protein with another. If a functionally equivalent amino acid is substituted, the protein may retain wild-type activity. Substitution may also diminish or eliminate protein function. Experimentally induced substitution is often used to study enzyme activities and binding site properties.
(12 Dec 1998)
amino acid transmitter <biochemistry> Amino acids released as neurotransmitter substances from nerve terminals and acting on postsynaptic receptors for example _ aminobutyric acid (GABA) and glycine that are fast inhibitory transmitters in the mammalian central nervous system.
Glutamate and aspartate mediate fast excitatory transmission. Strychnine (for glycine) and bicuculline for GABA) are blocking agents for amino acid action.
(18 Nov 1997)
aminocaproic acid <chemistry> A group of compounds that are derivatives of aminohexanoic acids.
<haematology> An antifibrinolytic agent, used to prevent bleeding in haemophilia, and after heart and prostate surgery when plasminogen or urokinase may be activated.
(05 Mar 2000)
aminocarboxylic acid <biochemistry> A class of organic molecules that containing an amino group and can combine in linear arrays to form proteins in living organisms.
There are twenty common amino acids: alanine, arginine, aspargine, aspartic acid, cysteine, glutamic acid, glutamine, glycine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine, and valine.
They are key components in all living things from which proteins are synthesised by formation of peptide bonds during ribosomal translation of messenger RNA.
All the amino acids have the L configuration, except glycine which is not optically active. Other amino acids occurring in proteins, such as hydroxyproline in collagen, are formed by post translational enzymatic modification of amino acid residues in polypeptide chains.
There are also several important amino acids, such as the neurotransmitter y aminobutyric acid, that have no relation to proteins.
Amino acids can now be produced by biotechnology in bulk using fermentation and biotransformation.
Acronym: AA
(13 Nov 1997)
aminocitric acid HOOCCH(NH3+)C(COOH)(OH)CH2CO; OH;found in acid hydrolysates of ribonucleoprotein in human spleen.
(05 Mar 2000)
aminoethanoic acid <amino acid, physiology> The simplest amino acid. It is a common residue in proteins, especially collagen and elastin and is not optically active.
It is also a major inhibitory neurotransmitter in spinal cord and brainstem of vertebrate central nervous system.
(18 Nov 1997)
aminoethylphosphonic acid <chemical> (2-aminoethyl)-phosphonic acid. An organophosphorus compound isolated from human and animal tissues.
Chemical name: Phosphonic acid, (2-aminoethyl)-
(12 Dec 1998)
aminolevulinic acid <chemical> Chemical name: Pentanoic acid, 5-amino-4-oxo-
(12 Dec 1998)
aminooxyacetic acid <chemical> (aminooxy)acetic acid. A compound that inhibits aminobutyrate aminotransferase activity in vivo, thereby raising the level of gamma-aminobutyric acid in tissues.
Pharmacological action: enzyme inhibitors, gaba agents.
Chemical name: Acetic acid, (aminooxy)-
(12 Dec 1998)
aminopropionic acid <amino acid> Alanine is a nonessential amino acid that can be manufactured by the body from other sources as needed. Alanine is one of the simplest of the amino acids and is involved in the energy-producing breakdown of glucose. In conditions of sudden anaerobic energy need, when muscle proteins are broken down for energy, alanine acts as a carrier molecule to take the nitrogen-containing amino group to the liver to be changed to the less toxic urea, thus preventing buildup of toxic products in the muscle cells when extra energy is needed. Because the body easily constructs alanine from other sources, no deficiency state is known. Alanine is found in a wide variety of foods, but is particularly concentrated in meats.
(22 May 1997)
anisic acid A crystalline volatile acid obtained from anise; its compounds are the antiseptic anisates.
Synonym: 4-methoxybenzoic acid.
(05 Mar 2000)
anthranilic acid One of the products of tryptophan catabolism.
Synonym: o-aminobenzoic acid.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 15
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 15
ÅëÇÕ°Ë»ö ¿Ï·á